The impact of drug shortages on patients with cardiovascular disease: Causes, consequences, and a call to action

Brent N. Reed, Erin R. Fox, Madeleine Konig, Cynthia A. Jackevicius, Frederick A. Masoudi, Alejandro Rabinstein, Robert L. Page

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Shortages of cardiovascular drugs have become increasingly common, representing an ongoing public health crisis. Given few therapeutic alternatives to many of the drugs in short supply, these shortages also pose a major challenge for cardiovascular care professionals. Although changes in the regulatory environment have led to some improvements in recent years, problems involving manufacturing processes remain the most common underlying cause. Because of the complex nature of drug shortages, sustainable solutions to prevent and mitigate them will require collaboration between regulatory agencies, drug manufacturers, and other key stakeholder groups. In this report, we describe the scope of the cardiovascular drug shortage crisis in the United States, including its underlying causes and the efforts currently being made to address it. Furthermore, we provide specific recommendations for how cardiovascular care professionals can be involved in efforts to limit the impact of drug shortages on patient care as well as policy changes aimed at preventing and mitigating them.

Original languageEnglish (US)
Pages (from-to)130-141
Number of pages12
JournalAmerican Heart Journal
Volume175
DOIs
StatePublished - May 1 2016

Fingerprint

Cardiovascular Diseases
Cardiovascular Agents
Pharmaceutical Preparations
Patient Care
Public Health
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The impact of drug shortages on patients with cardiovascular disease : Causes, consequences, and a call to action. / Reed, Brent N.; Fox, Erin R.; Konig, Madeleine; Jackevicius, Cynthia A.; Masoudi, Frederick A.; Rabinstein, Alejandro; Page, Robert L.

In: American Heart Journal, Vol. 175, 01.05.2016, p. 130-141.

Research output: Contribution to journalReview article

Reed, Brent N. ; Fox, Erin R. ; Konig, Madeleine ; Jackevicius, Cynthia A. ; Masoudi, Frederick A. ; Rabinstein, Alejandro ; Page, Robert L. / The impact of drug shortages on patients with cardiovascular disease : Causes, consequences, and a call to action. In: American Heart Journal. 2016 ; Vol. 175. pp. 130-141.
@article{3d124d2f43c74d2aa6cdf773aec1b89b,
title = "The impact of drug shortages on patients with cardiovascular disease: Causes, consequences, and a call to action",
abstract = "Shortages of cardiovascular drugs have become increasingly common, representing an ongoing public health crisis. Given few therapeutic alternatives to many of the drugs in short supply, these shortages also pose a major challenge for cardiovascular care professionals. Although changes in the regulatory environment have led to some improvements in recent years, problems involving manufacturing processes remain the most common underlying cause. Because of the complex nature of drug shortages, sustainable solutions to prevent and mitigate them will require collaboration between regulatory agencies, drug manufacturers, and other key stakeholder groups. In this report, we describe the scope of the cardiovascular drug shortage crisis in the United States, including its underlying causes and the efforts currently being made to address it. Furthermore, we provide specific recommendations for how cardiovascular care professionals can be involved in efforts to limit the impact of drug shortages on patient care as well as policy changes aimed at preventing and mitigating them.",
author = "Reed, {Brent N.} and Fox, {Erin R.} and Madeleine Konig and Jackevicius, {Cynthia A.} and Masoudi, {Frederick A.} and Alejandro Rabinstein and Page, {Robert L.}",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.ahj.2016.02.004",
language = "English (US)",
volume = "175",
pages = "130--141",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",

}

TY - JOUR

T1 - The impact of drug shortages on patients with cardiovascular disease

T2 - Causes, consequences, and a call to action

AU - Reed, Brent N.

AU - Fox, Erin R.

AU - Konig, Madeleine

AU - Jackevicius, Cynthia A.

AU - Masoudi, Frederick A.

AU - Rabinstein, Alejandro

AU - Page, Robert L.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Shortages of cardiovascular drugs have become increasingly common, representing an ongoing public health crisis. Given few therapeutic alternatives to many of the drugs in short supply, these shortages also pose a major challenge for cardiovascular care professionals. Although changes in the regulatory environment have led to some improvements in recent years, problems involving manufacturing processes remain the most common underlying cause. Because of the complex nature of drug shortages, sustainable solutions to prevent and mitigate them will require collaboration between regulatory agencies, drug manufacturers, and other key stakeholder groups. In this report, we describe the scope of the cardiovascular drug shortage crisis in the United States, including its underlying causes and the efforts currently being made to address it. Furthermore, we provide specific recommendations for how cardiovascular care professionals can be involved in efforts to limit the impact of drug shortages on patient care as well as policy changes aimed at preventing and mitigating them.

AB - Shortages of cardiovascular drugs have become increasingly common, representing an ongoing public health crisis. Given few therapeutic alternatives to many of the drugs in short supply, these shortages also pose a major challenge for cardiovascular care professionals. Although changes in the regulatory environment have led to some improvements in recent years, problems involving manufacturing processes remain the most common underlying cause. Because of the complex nature of drug shortages, sustainable solutions to prevent and mitigate them will require collaboration between regulatory agencies, drug manufacturers, and other key stakeholder groups. In this report, we describe the scope of the cardiovascular drug shortage crisis in the United States, including its underlying causes and the efforts currently being made to address it. Furthermore, we provide specific recommendations for how cardiovascular care professionals can be involved in efforts to limit the impact of drug shortages on patient care as well as policy changes aimed at preventing and mitigating them.

UR - http://www.scopus.com/inward/record.url?scp=84960921212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960921212&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2016.02.004

DO - 10.1016/j.ahj.2016.02.004

M3 - Review article

C2 - 27179732

AN - SCOPUS:84960921212

VL - 175

SP - 130

EP - 141

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

ER -